Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.47 -0.03 (-6.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Operating Expenses (2018 - 2026)

Updated

Reviva Pharmaceuticals Holdings (RVPH) posted Operating Expenses of $2.62 million for Q2 2026, down 56.9% from $6.07 million a year earlier and down 20.0% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Operating Expenses (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Reviva Pharmaceuticals Holdings was $13.48 million, down 50.7% year-over-year; for FY2025, it was $20.2 million, down 34.4% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of 52.7% (FY2020 to FY2025).
  • In prior years, Reviva Pharmaceuticals Holdings' Operating Expenses was $30.8 million in FY2024 (-22.0%), $39.5 million in FY2023 (+39.9%), $28.23 million in FY2022 (+179.4%) and $10.1 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Operating Expenses since Q3 2021.
  • On a year-over-year basis, Operating Expenses has declined in each of the last nine quarters, with an average decline of 38.4% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q1 2022, with growth of 298.0%; the weakest was Q2 2026, with a decline of 56.9%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $3.27 million (Q1 2026), $3.56 million (Q4 2025) and $4.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Reviva Pharmaceuticals Holdings 6.16 Mn 6.16 Mn - 2.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.62 Mn
Mar 31, 2026 3.27 Mn
Dec 31, 2025 3.56 Mn
Sep 30, 2025 4.03 Mn
Jun 30, 2025 6.07 Mn
Mar 31, 2025 6.54 Mn
Dec 31, 2024 6.28 Mn
Sep 30, 2024 8.46 Mn
Jun 30, 2024 8.13 Mn
Mar 31, 2024 7.92 Mn
Dec 31, 2023 9.62 Mn
Sep 30, 2023 11.56 Mn
Jun 30, 2023 11.34 Mn
Mar 31, 2023 6.98 Mn
Dec 31, 2022 8.89 Mn
Sep 30, 2022 5.50 Mn
Jun 30, 2022 5.52 Mn
Mar 31, 2022 7.45 Mn
Dec 31, 2021 3.96 Mn
Sep 30, 2021 2.48 Mn
API Access

Reviva Pharmaceuticals Holdings Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=RVPH&period=max&api_key=YOUR_API_KEY